No benefit from azithromycin in patients hospitalised with COVID-19

New data from the RECOVERY trial 'convincingly rule out any meaningful clinical benefit of azithromycin in the hospitalised COVID-19 patients we studied', say researchers.

Please sign in or register for FREE

No comments yet.